Cyntegrity | Data Science for Clinical Trials
Follow Us on LinkedIn

Responsible AI
in Clinical Trials

Stay informed with AI industry insiders! Register for the 2nd annual virtual summit on October 8 and 9, 2024.

Thank you! Your registration has been successfully submitted. By September, you will receive a personal invite with a webinar link.

Returning and New Powerhouses:
Microsoft, MongoDB, PwC & Halloran

Building on last year's success, these industry leaders have already secured speaker slots for this year's summit. Don't miss their invaluable insights.

If your organization is interested in contributing to the dialogue as a speaker of panelist, please get in touch with us.
AI Futurescape

From Bots to Agents:
The Evolution of AI in Clinical Trials

As AI technology evolves from simple bots to sophisticated agents, the potential for its application in clinical trials expands significantly. This summit will explore the journey of AI development and its implications for the clinical trials industry.

Like last year, we are approaching speakers to ensure an impressive line-up for the 2024 summit. Below, you will find the esteemed speakers from last year's event. Each speaker, panelist, and moderator will bring expertise and insights, promising enriching discussions that probe profoundly into the nuances of responsible AI.

Danny Goh, Founder and CEO of Nexus FrontierTech

Danny Goh

Nexus FrontierTech
Meghan Conroy, Founder of CAPTUREPROOF

Meghan Conroy

Wole Moses, Sr Dir US Federal Growth Strategy at Microsoft

Wole Moses

Francesc Mateu, Principal, Healthcare Industry Solutions at MongoDB

Francesc Mateu

Kai Eckert, Professor for AI Department of Computer Science at Mannheim University of Applied Sciences

Prof Kai Eckert

Mannheim University of AS
Moe Alsumidaie, Head of Research at CliniBiz

Moe Alsumidaie

Nechama Katan, Dir Innovative Data Analytics at Pfizer

Nechama Katan

Big Pharma
Adam Baumgart, Consultant and Owner of Alcedo Consulting Ltd

Adam Baumgart

Alcedo Consulting
Hendrik A. Reese, Artificial Intelligence Partner, PwC Germany

Hendrik A. Reese

PwC Germany
Linda Bunschoten, CMO at Cyntegrity

Linda Bunschoten

Dr Johann Proeve, Chief Scientific Officer at Cyntegrity

Johann Proeve

Keith Dorricott, Lead Trainer MyRBQM Academy, Cyntegrity

Keith Dorricott

MyRBQM Academy
Event Details

Event Details

We look forward to your participation in this community-building, free event, shaping the responsible use of AI in clinical trials.

For any questions or additional details please reach out to Tamara Beck, our MyRBQM Academy Operations Manager, at:

Event Dates


October 8 & 9, 2024

Event Time


15:00 - 17:30 CEST | 9:00 AM - 11:30 AM EDT

Event Format


Virtual, 2 webinars of 2.5 hours each

Preliminary Agenda

Preliminary Agenda

Spreading over two days with sessions lasting 2.5 hours each, this free event aims to foster meaningful dialogue on Responsible AI in clinical trials.


  • Introduction & Welcome Remarks - Event objectives & the importance of AI in clinical trials
  • AI as an Assistant - What are the practical applications of AI as an assistant, and how can it be supervised effectively to ensure accurate and reliable outcomes?
  • Bias and Fairness - How can we identify and mitigate biases in AI algorithms used in clinical trials, and what steps can be taken to ensure these models are fair and unbiased?
  • Change Management (Stakeholder and Panel Discussion) - What strategies can be employed to manage change and foster acceptance of AI in clinical trials, and how can organizations involve stakeholders early in the AI implementation process?
  • Q/A & Closing Remarks


  • Recap Day 1 - Insights & Observations
  • Real-World Applications - What are some successful case studies of AI implementation in clinical trials, and what lessons can be learned from these to guide future AI projects?
  • Latest Legislations Concerning AI - What are the latest regulatory updates and guidelines for AI in clinical trials, and how can organizations navigate the regulatory landscape to ensure compliance while leveraging AI?
  • Future Trends (Stakeholder and Panel Discussion) - What are the emerging trends in AI technology that could impact clinical trials, and how can organizations stay ahead of the curve and prepare for future AI advancements?
  • Q/A & Closing Remarks - Summary & next steps for Responsible AI

Who Should Join the Dialogue?

Directors and Senior Managers specializing in: Clinical Operations & Study Management, Innovation & New Technologies, Clinical Monitoring & Site Management, Project & Program Management

Heads of Therapeutic Areas and Medical Affairs

Functional Leads in Data Management and Biostatistics

Compliance and Quality Assurance Officers

Regulatory Affairs Executives

Artem Andrianov, Co-founder & CEO of Cyntegrity

We're on the verge of a new era in clinical trials, where AI processes data and understands human emotions and preferences.

Let's leverage AI's power to create a future where technology and humanity collaborate to improve healthcare outcomes.

Artem Andrianov, PhD

CEO & Founder of Cyntegrity

Got 10 Minutes?

How do you see the future of AI in clinical trials? Help us understand the impact of AI in clinical trials.

AI-Augmented RBQM Solutions

©2024 Cyntegrity - All Rights Reserved

Cyntegrity | Data Science for Clinical Trials